Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Robert D. Schwab"'
Autor:
Robert D. Schwab, Stephen Bagley, Zev Binder, Robert Lustig, Donald O’Rourke, Steven Brem, Arati S. Desai, MacLean Nasrallah
Publikováno v:
Journal of Clinical and Translational Science, Vol 2, Pp 45-45 (2018)
OBJECTIVES/SPECIFIC AIMS: In patients with recurrent glioblastoma (GBM) who undergo a second surgery following standard chemoradiotherapy, histopathologic examination of the resected tissue often reveals a combination of viable tumor and treatment-re
Externí odkaz:
https://doaj.org/article/d5fb791f26ca4bae9b539b7ae80dfd0e
Autor:
Robert D. Schwab, Selina M. Luger
Publikováno v:
Current Treatment Options in Oncology.
Publikováno v:
Cell. 186:1814-1814.e1
Autor:
Luka M. Devenica, Obinna Ukogu, Ryan B. McMillan, Ashley R. Carter, Yuxing Ma, Ashwin Balaji, Robert D. Schwab, Adam D. Smith, Hilary Bediako, Shahzad Anwar, Moumita Dasgupta
Publikováno v:
Nucleic Acids Research
Protamine proteins dramatically condense DNA in sperm to almost crystalline packing levels. Here, we measure the first step in the in vitro pathway, the folding of DNA into a single loop. Current models for DNA loop formation are one-step, all-or-not
Autor:
Arati Desai, MacLean Nasrallah, Stephen J Bagley, Angela N. Viaene, Zev A. Binder, Robert A. Lustig, Steven Brem, Ernest Nelson, Donald M. O'Rourke, Robert D. Schwab
Publikováno v:
Journal of Neuro-Oncology. 141:421-429
The prognostic impact of the histopathologic features of recurrent glioblastoma surgical specimens is unknown. We sought to determine whether key histopathologic characteristics in glioblastoma tumors resected after chemoradiotherapy are associated w
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2086
Chimeric antigen receptor (CAR) T cell therapies are ex vivo manufactured cellular products that have been useful in the treatment of blood cancers and solid tumors. The quality of the final cellular product is influenced by several amenable factors
Publikováno v:
Methods in Molecular Biology ISBN: 9781071601457
Chimeric antigen receptor (CAR) T cell therapies are ex vivo manufactured cellular products that have been useful in the treatment of blood cancers and solid tumors. The quality of the final cellular product is influenced by several amenable factors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::325309cc011296b7e6ebb285151a1634
https://doi.org/10.1007/978-1-0716-0146-4_15
https://doi.org/10.1007/978-1-0716-0146-4_15
Autor:
Kathleen M. Haines, Alexandria P. Cogdill, Decheng Song, Laura A. Johnson, John Scholler, Carl H. June, Regina M. Young, Boris Engels, Avery D. Posey, Michael Feldman, Taylor J. Chen, Catharina Steentoft, David M. Kranz, Thomas Daugbjerg Madsen, Robert D. Schwab, Ulla Mandel, Hans Schreiber, Henrik Clausen, Karin Schreiber, Brian Keith, Alina C. Boesteanu, Jennifer D. Stone
Publikováno v:
Immunity. 44:1444-1454
Genetically modified T cells expressing chimeric antigen receptors (CARs) demonstrate robust responses against lineage restricted, non-essential targets in hematologic cancers. However, in solid tumors, the full potential of CAR T cell therapy is lim
Publikováno v:
Seminars in Oncology. 43:291-299
Adoptive cell immunotherapy for the treatment of chronic lymphocytic leukemia (CLL) has heralded a new era of synthetic biology. The infusion of genetically-engineered, autologous chimeric antigen receptor (CAR) T cells directed against CD19 expresse
Autor:
Stephen J, Bagley, Robert D, Schwab, Ernest, Nelson, Angela N, Viaene, Zev A, Binder, Robert A, Lustig, Donald M, O'Rourke, Steven, Brem, Arati S, Desai, MacLean P, Nasrallah
Publikováno v:
Journal of neuro-oncology. 141(2)
The prognostic impact of the histopathologic features of recurrent glioblastoma surgical specimens is unknown. We sought to determine whether key histopathologic characteristics in glioblastoma tumors resected after chemoradiotherapy are associated w